BioHouston Content Managers RSS Feed

Biotechnology Commercialization Center (BCC)

Tue, 03 Jan 2012 18:42:12 GMT

BioHouston has partnered with UT Health for the expansion of wet laboratory facilities available to life science companies. The Biotechnology Commercialization Center (BCC), which is located at The University of Texas Health Science Center at Houston (UTHealth), is available for the incubation of startup companies. The mission of the center is to help facilitate the next breakthrough in the diagnosis or treatment of disease by providing office, laboratory and conference space, as well as access to UTHealth equipment and core analytical facilities. BioHouston's science laboratory equipment has been relocated to the BCC. The BCC's proximity to other institutions in the Texas Medical Center provides valuable access to information, collaboration and expertise. The BCC consists of over 20,000 sq. ft of laboratory and office space on three adjacent floors. ...

Board--Executive Committee--Given

Fri, 28 Oct 2011 15:37:51 GMT

Bruce D. Given, M.D.
Chairman
ICON plc

Dr. Given serves as a Healthcare Products Consultant as the Principal of Bruce Given Consulting. Until June of 2007, Dr. Given served as President and Chief Executive Officer and as a member of the Board of Directors of Encysive Pharmaceuticals, which he joined in 2002. Prior to joining Encysive Pharmaceuticals, he was with Johnson & Johnson for 9 years, serving in several capacities including as President, International, Ortho-Clinical Diagnostics and as Group Vice President, Head of U.S. Marketing & Sales, Research & Development for Janssen Pharmaceutica. He has held various executive and senior management positions at Sandoz Pharma Ltd., Sandoz Research Institute and Schering-Plough Corporation. Prior to entering the pharmaceutical industry, he was on the medical faculty at the University of Chicago.

Dr. Given obtained his bachelor of sciences degree from Colorado State University, graduating Phi Beta Kappa. He received his M.D. degree with honors from the University of Chicago, Pritzker School of Medicine and completed his medical training at the University of Chicago and at Brigham and Women’s Hospital in Boston, where he was a Clinical Fellow at Harvard Medical School. He is board certified in internal medicine and endocrinology and metabolism and has authored 33 scientific publications.

Dr.Given serves on the Boards of Directors for ICON Plc and BioHouston, is a member of the Technology Review Committee of MD Anderson Medical Center and is past Chairman of the Rider University Scientific Advisory Board.

Board: Daniel J. Moore

Fri, 16 Sep 2011 15:07:36 GMT

Daniel J. Moore.
President & Chief Executive Officer
Cyberonics, Inc.

Dan Moore became President and Chief Executive Officer of Cyberonics in May 2007. During the first three years of his tenure, the Company resumed meaningful epilepsy revenue growth and returned to profitability after multiple years of losses. Net sales for fiscal year 2010 were $167.8 million resulting in income from operations of $36.9 million. Under the direction of Mr. Moore and his senior management team, Cyberonics is focused on introducing medical devices and expanding Vagus Nerve Stimulation (VNS) Therapy® franchise for patients suffering from epilepsy.

Cyberonics has approximately 500 employees world-wide, with more than 430 in the U.S. Cyberonics’ stock is traded on the NASDAQ stock exchange under the symbol CYBX.

Mr. Moore joined Cyberonics from Boston Scientific where, since 1989, he held positions in sales, marketing and senior management in the United States and in Europe. In his last position at Boston Scientific, he was President, International Distributor Management. Prior to this, he was President, Inter-Continental, the fourth largest business unit of Boston Scientific with more than 1,000 global employees and revenues exceeding $700 million. Mr. Moore began his career with Procter and Gamble after graduating from Harvard College. He also earned an MBA from Boston University.

In addition to Cyberonics, he serves on the boards of Trivascular, Inc., Medical Device Manufacturers Association (MDMA), BioHouston, Weldon School of Biomedical Engineering at Purdue University, the Epilepsy Foundation of Texas and the National Epilepsy Foundation.

Board: Paul Klotman

Fri, 16 Sep 2011 15:00:40 GMT

Paul Klotman, M.D.
President & CEO
Baylor College of Medicine

Paul Klotman, M.D., assumed the post of President and CEO at Baylor College of Medicine Sept. 1, 2010. Dr. Klotman received his B.S. degree in 1972 from the University of Michigan and his M.D. from Indiana University in 1976. He completed his Medicine and Nephrology training at Duke University Medical Center. He stayed at Duke as a faculty member, rising to the rank of Associate Professor of Medicine before moving to the NIH in 1988 where he became Chief of the Molecular Medicine Section in the Laboratory of Developmental Biology. In 1993, he became Chief of the Viral Pathogenesis Laboratory in the NIDR/NIH. In 1994 he moved to Mt. Sinai School of Medicine as the Irene and Dr. Arthur M. Fishberg Professor of Medicine and the Chief, Division of Nephrology. In 2001, he was selected to be the Chairman of the Samuel Bronfman Department of Medicine. Dr. Klotman is a noted scientist whose work has included both basic and clinical research in molecular virology and AIDS pathogenesis. He has been an active clinician, teacher, and mentor.

CEO Dinner

Fri, 12 Aug 2011 15:48:40 GMT

The leaders of Houston region's growing biotechnology industry know the challenges of running a life science company. The CEO Dinner is an opportunity for these leaders to get to know and network with each other in a informal setting, away from the workplace and in one of Houston's finer establishments. These meetings feature a guest speaker pertinent to the industry and plenty of opportunity for networking and discussion. Open only to Life Science company CEO's, this exclusive dinner allows these executives the opportunity to frankly discuss their industry.

For more information, please contact Elizabeth Hicks at 713.979.9106.

Associate Advisory Board

Tue, 14 Jun 2011 13:36:34 GMT

Meg Boulware - Chair Baker & McKenzie LLP Danguole Altman Vapogenix William Altman CorInnova Bill Arend Oracle Meredith Brown AlphaDev Wendy Burke Linbeck Hoagy Cannon Vaughn Construction David Carter Capital Royalty Michael Coleman Ingeneron John Farrell FKP Architects Bruce Given ICON plc Chyau Liang Osha Laing LLP ...

BioHouston Breakfast Forum

Mon, 23 May 2011 21:53:44 GMT

Tuesday, June 21st, 2011 7:30 AM- 9:00 AM James T. Willerson, MD, President, Texas Heart Institute James T. Willerson, MD, is the president and medical director, director of Cardiology Research, and co-director of the Cullen Cardiovascular Research Laboratories at Texas Heart Institute (THI). In 1989, he was named the Edward Randall III Chair, Department of Internal Medicine at The University of Texas Medical School at Houston. He was president of The University of Texas Health Science Center at Houston from 2001 to 2008 and was named the Alkek-Williams Distinguished Professor there at the same time. Dr. Willerson was appointed president-elect of THI in 2004 and became president and medical director in 2008. He is also an adjunct professor of Medicine at Baylor College of Medicine and at The University of Texas MD Anderson Cancer Center. He is the former chief of Cardiology at St. Luke's Episcopal Hospital and the former chief of...

8th Annual Chili Cook-Off

Tue, 03 May 2011 19:50:25 GMT

Put a little SPICE in your life...; 8th Annual BioHouston Chili Cook-Off April 1st, 2011 View Some Pictures of The Event! Chili Cook-Off Video! Watch The Fun In Action! 8th Annual BioHouston Chili Cook-Off Winners: Best of Show: CitareTx Investment Partners Hottest Chili: JE Dunn Construction Best Traditional Chili: CitareTx Investment Partners Best Non-Traditional Chili: PhiloWilke Partnership / Tribble & Stephens Construction Hula-Hoop Champ: Jiefeng Chen, inVentiv Clinical Solutions Jalepeno Eating Champ: Kevin Hlavinka, Cyberonics Limbo Champ: Michelle Albright, Lexicon Pharmaceuticals Best Dessed Team: Texas Heart Institute Most Unique Team: Texas Heart Institute Best Themed Team: Texas Heart Institute ...

Michael E. Debakey Life Science Award

Tue, 19 Apr 2011 14:44:17 GMT

The Michael E. DeBakey Memorial Life Science Award is given each year to the undiscovered life science company with the highest potential to commercialize an important product at the annual Texas Life Science Conference. The first DeBakey Award was given to ThromboVision, Inc. in 2006. Dr. DeBakey's rich history in Houston and the Texas Medical Center, along with his pioneering spirit, truly embodied the qualities that we are seeking in future recipients of this award. Some of Dr. DeBakey's most renowned contributions included the concept of the Mobile Army Surgical Hospitals (MASH units), performing the first successful artificial heart transplant, playing an instrumental role in the development of the Ventricular Assist Device (VAD) and being the first to successfully implant the device into a human. Additionally, he served as consultant to almost every U.S. President in this century and received many prestigious awards, including the Presidential Medal of Freedom with...

2011 Chili Cook-Off Team Information

Sun, 06 Mar 2011 22:45:57 GMT

Team Registration So, you think you've got an award winning chili recipe? Well put it to the test by entering a team in the 8th Annual BioHouston Chili Cook-Off! Chili Cook-Off Team Rules: 1. Each team will be allotted a 12'x12' space. As space is limited, you must ensure that your tents and ropes will fit inside this area. 2. Chili may be cooked on-site or prepared ahead to ensure chili is ready for judging. 3. Propane burners are allowed for cooking - no gas powered generators or barbecue rigs allowed. Please be sure your cooking equipment is in safe working condition. 4. No power outlets will be available to any teams. Please make sure you have the appropriate equipment should you need power. 5. Teams are responsible for supplying all their equipment needed - tables, chairs, tent, cooking equipment, serving utensils, etc. 6. Teams need to prepare enough chili to allow for sampling by all judges. Extra...

Board--Executive Committee--Cunningham

Fri, 11 Feb 2011 16:24:44 GMT

Joe H. Cunningham, M.D.
Managing Director
Santé Ventures

Prior to founding Santé, Joe was a healthcare Venture Partner with Austin Ventures and was previously the Vice Chair of the Ascension Health Ventures investment committee. He is also the former Chief Medical Officer of the Providence Health System and Executive Director of the 300-physician Providence Health Alliance, both of which belong to the Ascension Health system. He has extensive management experience and is recognized nationally for his expertise in healthcare delivery systems, physician associations and compensation models. Joe currently serves on advisory boards for both Health Services Corporation (BC/BS) and United Healthcare. He is board certified in both Internal Medicine and Quality Assurance and Peer Review. Joe received his BS and MD degrees from Texas A&M University and his MBA from Baylor University.

Technology Transfer Luncheon

Mon, 11 Oct 2010 19:23:05 GMT

With more than 40 institutions in the Texas Medical Center and the many additional academic, healthcare and research institutions in the region performing more than $1.8 million in research annually, discoveries of exciting new technologies happen all the time.

The technology transfer office at each institution is the first step towards commercialization of these discoveries. To facilitate interaction between these offices and the investors and life science companies in our region, we host these monthly luncheons.

At each luncheon, a topic of discussion is chosen, and each institution will bring one or more technologies from that arena to review with the group. It may just be an early-stage discovery that has exciting potential, or it may be a patented process ready for licensing. Either way, this is a great opportunity to be in on the ground floor as the discoveries of today become the life-saving products of tomorrow.

Past Meeting Topics:

Biomarkers
Anti-infective Therapeutic and Prophylactic Vaccines
Micro-/Nanoarrays and Medical Devices, including Combination Devices
Immunotherapy
Drug Delivery Systems
Diagnostics
Devices

For more information, please contact Sara Mathews at 713-979-9106.

2010 Annual Luncheon

Mon, 11 Oct 2010 18:20:24 GMT

BioHouston Annual Luncheon-- The Annual Luncheon is attended by the Who's Who of the Houston. By celebrating the achievements of women leaders in science, BioHouston's goal is to inspire others to pursue research and applications that will spur economic growth and prosperity for our region and our state as a whole. Table sales now open! Click Here for an Underwriting Commitment Form -- Seating is limited. This year's Honorees are: Pam Darwin, Vice President, Geoscience, ExxonMobil Production Company Renata Pasqualini, Ph.D., Professor, The University of Texas M.D. Anderson Cancer Center, Department of...

Panasonic Healthcare Day

Tue, 10 Aug 2010 00:18:42 GMT

PANASONIC HEALTHCARE DAY Presented with BioHouston All events at Trevisio's-Texas Medical Center 7:30 a.m. - 9:00 a.m BioHouston Breakfast Forum featuring Joe Taylor, Chairman and CEO of Panasonic Corporation of North America -- Sponsored by Panasonic Corporation of North America 9:00 a.m. - 1:30 p.m. Panasonic Showcase Display 11:30 a.m. - 1:30 p.m. Complimentary Lunch for Attendees of Panasonic Showcase 5:00 p.m. - 6:30 p.m. Cocktail Reception for Hospital CEOs and Executives You must register for each event separately. To register for the Breakfast Forum featuring Joe Taylor, Click Here To register for the Show Case and Complimentary Lunch, Click Here To...

Board--Executive Committee--McWilliams

Wed, 07 Jul 2010 21:55:17 GMT

David McWilliams

Mr. McWilliams has over 30 years experience in building biopharmaceutical and healthcare companies. He has been the chief executive officer of five startups, including Encysive Pharmaceuticals (ENCY) and Repros Therapeutics (RPRX). Previously he was President and CEO of several diagnostic healthcare companies, a senior executive at Abbott Laboratories and a management consultant with McKinsey & Co. He received an MBA in Finance from the University of Chicago and a BA in Chemistry, Phi Beta Kappa, from Washington and Jefferson College. Mr. McWilliams is a director of Novelos Therapeutics, Norwell Inc. and ApoCell Biosciences.

** Service Template - User Discussion Groups

Wed, 02 Sep 2009 16:47:36 GMT

User Discussion Groups

** Service Template - Featured Techology

Wed, 02 Sep 2009 16:44:49 GMT

FEATURED TECHNOLOGY

LOREM IPSUM
Consectetuer adipiscing elit, sed nonum nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.

Featured by:

** Registered User Template - Featured Researcher

Wed, 02 Sep 2009 16:42:00 GMT

FEATURED RESEARCHER

Consectetuer adipiscing elit, sed nonum nibh euismod tincidunt ut laoreet dolore magna aliquam erat volutpat.